title: Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases.
authors.affiliation: Gastroenterology and Gastrointestinal Endoscopy Service and Angelo Bianchi Bonomi Haemophilia and Thrombosis Center, Department of Internal Medicine and Dermatology, IRCCS Maggiore Hospital, University of Milan, Via Pace 9, 20122 Milan, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Saibeni
authors.forename: B
authors.initials: B
authors.lastname: Bottasso
authors.forename: L
authors.initials: L
authors.lastname: Spina
authors.forename: M
authors.initials: M
authors.lastname: Bajetta
authors.forename: S
authors.initials: S
authors.lastname: Danese
authors.forename: A
authors.initials: A
authors.lastname: Gasbarrini
authors.forename: R
authors.initials: R
authors.lastname: de Franchis
authors.forename: M
authors.initials: M
authors.lastname: Vecchi
mesh_terms: D000328:Adult; D025901:Carboxypeptidase B2 / Q000097:blood*; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000097:blood*; D008297:Male
chemical_list: D025901:Carboxypeptidase B2